Dr Behzad Hajarizadeh – Hepatitis C treatment-as-prevention in Australian prisons: the SToP-C study

Event type: 
Event date: 
Tuesday, 27 October 2020 - 1:00pm to 2:00pm

Webinar via Microsoft Teams Live Event
Please click on this link just before the start of the webinar to join

Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or recpt@kirby.unsw.edu.au
Booking deadline: 


Kirby Institute Seminar Series presents

Dr Behzad Hajarizadeh  

Dr Behzad Hajarizadeh
Senior Lecturer, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney

Behzad Hajarizadeh is a clinical epidemiologist, and a Senior Lecturer at the Kirby Institute, UNSW Sydney. He trained as a Medical Practitioner and has an MPH and PhD in Medicine. His research interests include viral hepatitis natural history, and clinical care in prison settings and among people who inject drugs.



Treatment-as-prevention incorporates treatment as a tool for limiting spread of an infection in epidemics in a particular setting. The Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) study is the first study globally, providing empirical data of hepatitis C treatment-as-prevention in the prison setting.